INmune Bio, Inc. announced that the company has entered into a pre-clinical research collaboration with Chinese University of Hong Kong to evaluate INKmune™ in nasopharyngeal cancer, a type of head and neck cancer.
[INmune Bio, Inc.]
Sorry, but the selected Zotpress account can't be found.
